IBM (NYSE:IBM) Shares Recover, While $10.9 Billion Cash Flow Hurdle Approaches

U.S. markets remain shut, with the most recent price at $214.19 from Friday. IBM climbed 3.65% during that session, trading 10.58 million shares. Despite the recovery, the stock is still down 26.2% from the July 13 close. IBM shares plunged nearly 25% in a single session following the July 14 warning. The company’s market capitalization was about $204.2 billion, based on Friday’s closing price.

IBM posted second-quarter revenue of $17.16 billion, representing a 1% increase from a year earlier. The figure missed LSEG’s consensus estimate of $17.58 billion by $420 million. Adjusted earnings per share reached $2.93, compared to expectations of $2.97. GAAP net income came in at $2.17 billion, a slight decline year over year. While the earnings and revenue gaps were limited, operational execution was a bigger concern.

IBM currently projects a constant-currency revenue increase of 4% to 5%, revising its prior outlook of growth above 5% for the full year. The neutral impact of currency suggests revenue between approximately $70.2 billion and $70.9 billion. The midpoint of 4.5% is below LSEG’s consensus growth forecast of 4.8%. Management continues to project about $1 billion growth in free cash flow. Based on a baseline of $14.7 billion for 2025, this suggests free cash flow will reach around $15.7 billion.

IBM Z revenue dropped 42%, leading to a 7% decrease in infrastructure revenue. Transaction Processing software recorded an 8% fall over the second quarter. Management reported around one-third of postponed deals have closed so far in Q3. IBM notes z17 remains at roughly 130% compared to the same stage for z16. Clients covering 85% of the installed mainframe base either kept or raised their usage levels. These data points are consistent with a pattern of deferral, though the timing of deals and customer budgets is still unclear.

Software revenue reached $7.76 billion, up 5%, but below the $7.88 billion consensus. Red Hat saw an 11% increase, and the Data segment advanced 19%. Automation gained 4%, while Transaction Processing dropped 8%. While higher-growth segments remained strong, software tied to mainframe performance softened overall results. Investors need sustained gains in Red Hat and Data to counteract ongoing mainframe-related weakness.

Consulting revenue totaled $5.3 billion, unchanged on a reported basis and rising 1% in constant currency. Generative AI accounted for roughly 50% of signings and more than 30% of the backlog. Profit margin for the segment improved by 160 basis points due to productivity measures. Bookings remain robust. Revenue, however, saw minimal change. Third-quarter results will show if AI demand is translating into recognized sales.

IBM reported first-half free cash flow of $4.8 billion, matching the prior year. The company distributed about $3.2 billion in dividends over the same period. Free cash flow covered dividends for the first half by approximately 1.5 times. With a stock price of $214.19, the annualized dividend of $6.76 yields about 3.16%. Dividend coverage remains contingent on stronger cash flow and guidance being met in the second half.

Cash and securities declined by $6.3 billion from the end of the previous year, reaching $8.2 billion at the end of June. Total debt, which includes financing debt, stood at $62.0 billion, an increase of $0.7 billion compared with year-end levels. IBM spent $10.5 billion on acquisitions in the first half. The company expects to spend more than $10 billion on quantum initiatives over five years. The value of HRL’s acquisition remains undisclosed, leaving short-term funding requirements unclear. While current data indicates available capacity, lower cash levels and increased commitments have tightened the buffer.

IBM ended Friday trading at nearly 19 times trailing earnings, with a market capitalization of about $204.2 billion. Based on that valuation, a projected $15.7 billion cash target represents an estimated yield of roughly 7.7%. The annualized dividend yield is around 3.16% at the prevailing share price. These figures appear more reasonable following the July drop. Still, the cash estimate is implied and largely hinges on outcomes in the remainder of the year.

IBM has set October 21 as the provisional date for its third-quarter earnings release. There are no scheduled IBM investor events in the upcoming week. The primary company concern continues to be the status of postponed large deals. According to management, one-third of these deals have now concluded, with the rest yet to be confirmed. Investors will keep an eye on software growth, demand for mainframes, and free cash flow. In the absence of new company releases, share price changes are likely to be driven by sentiment rather than concrete updates.